ReviewComprehensive review on current developments of quinoline-based anticancer agents
-
Add time:09/08/2019 Source:sciencedirect.com
Among heterocyclic compounds, quinoline scaffold has become an important construction motif for the development of new drugs. Quinoline and its derivatives possess many types of biological activities and have been reported to show significant anticancer activity. Quinoline compounds play an important role in anticancer drug development as they have shown excellent results through different mechanism of action such as growth inhibitors by cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration and modulation. A number of quinoline derivatives have been reported till date for their anticancer activity. The present review, summarizes various mono-, di-, tri-, tetra- and heterocyclic substituent quinoline derivatives with potential anticancer activity. Their mechanism of action and possible structure activity relationship has also been discussed.
We also recommend Trading Suppliers and Manufacturers of 3-Bromo-6-hydroxy quinoline (cas 13669-57-3). Pls Click Website Link as below: cas 13669-57-3 suppliers
Prev:Synthesis and anticoccidial activities of novel ethyl 6-aryloxy-7-bromo-4-hydroxy-3-quinolinecarboxylate against Eimeria tenella
Next:Acetylene-free synthesis of vinyloxy pyridine and quinoline) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis of novel 3,4,6-trisubstituted quinolines enabled by a Gould-Jacobs cyclization09/26/2019
- ReviewMetal complex catalysis in the synthesis of quinolines09/25/2019
- Review articleA review on anticancer potential of bioactive heterocycle quinoline09/24/2019
- 4 - Natural and synthetic quinoline molecules against tropical parasitic pathologies: an analysis of activity and structural evolution for developing new quinoline-based antiprotozoal agents09/10/2019
- Acetylene-free synthesis of vinyloxy pyridine and quinoline09/09/2019
- Synthesis and anticoccidial activities of novel ethyl 6-aryloxy-7-bromo-4-hydroxy-3-quinolinecarboxylate against Eimeria tenella09/07/2019
- Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists09/06/2019
-
Health and Chemical more >


